To investigate the association of the GOLD ABCD groups classification with costs and health-related quality of life (HR-QoL) and to compare this with the GOLD 1234 ...
The GOLD 2023 and 2024 reports recommend that health professionals consider triple therapy (TT) entailing combined use of a long-acting β 2 agonist (LABA), a long-acting muscarinic antagonist (LAMA), ...
Neither the 2007 nor the 2011 Global Initiative for Chronic Obstructive Lung Disease (GOLD) classification systems have sufficient prognostic accuracy to predict mortality, a pooled analysis of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback